RH-109
冻干新型冠状病毒奥密克戎株mRNA疫苗 (武汉瑞科吉生物)
Report date: 2026/05/13 09:17:19
Base Information
Drug NameRH-109
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesWuhan Recogen Biotechnology Co LtdJiangsu Rec-Biotechnology Co LtdShenzhen Ruiji Biological Technology Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A